Skip to main content

Table 1 Genetic variants associated with NHCRC after meta-analyses of at least three independent datasets (primary meta-analyses)

From: Single nucleotide polymorphisms and sporadic colorectal cancer susceptibility: a field synopsis and meta-analysis

Gene

SNPs

Chr

Allelesa

Datasets

Cases

Controls

OR

CI-U

CI-L

P

FDR

Venice criteria

Level of evidence

BMP2

rs961253

20

C-A

23

40507

40740

1.121

1.098

1.144

7.77E−27

7.15E−25

AAA

High

CASC8

rs10505477

8

T-C

13

12933

13259

0.856

0.828

0.886

9.27E−19

2.84E−17

AAA

High

BMP4

rs4444235

14

T-C

27

39030

39934

1.083

1.061

1.105

8.24E−15

1.89E−13

AAA

High

SMAD7

rs12953717

18

C-T

9

10782

10011

1.163

1.118

1.209

4.93E−14

8.00E−13

AAA

High

CCAT2

rs6983267

8

G-T

26

33098

30415

0.845

0.807

0.884

3.35E−13

3.86E−12

AAA

High

TGF-β1

rs1800469

19

C-T

21

17404

36234

0.911

0.887

0.936

1.59E−11

1.62E−10

AAA

High

LOC105376400

rs10795668

10

G-A

8

5744

5481

0.837

0.791

0.886

8.43E−10

5.27E−09

AAA

High

GREM1-SCG5

rs4779584

15

C-T

16

25151

24548

1.154

1.093

1.217

1.69E−07

8.62E−07

AAA

High

ADIPOQ

rs2241766

3

T-G

7

2400

2972

1.216

1.115

1.326

9.33E−06

3.07E−05

AAA

High

miR-27a

rs895819

19

T-C

5

1562

1852

1.192

1.076

1.320

0.001

0.002

AAA

High

ADIPOR1

rs1342387

1

G-A

5

1843

2563

0.824

0.755

0.900

1.82E−05

5.76E−05

ABA

Intermediate

ICAM1

rs5498 469

19

A-G

3

358

335

0.740

0.595

0.920

0.007

0.012

BAA

Intermediate

PARP-1

rs1136410

1

T-C

3

808

1849

1.181

1.043

1.337

0.009

0.015

ABA

Intermediate

RHPN2

rs10411210

19

C-T

15

22299

23280

0.881

0.844

0.919

6.12E−09

4.69E−08

ABC

Low

SMAD7

rs4464148

18

T-C

8

9736

8573

1.142

1.091

1.196

1.62E−08

1.15E−07

AAC

Low

SMAD7

rs4939827

18

T-C

17

16336

15443

0.859

0.813

0.908

5.94E−08

3.42E−07

ACA

Low

CDH1

rs9929218

16

G-A

17

22459

24079

0.930

0.903

0.958

1.51E−06

5.80E−06

AAC

Low

COLCA1

rs3802842

11

A-C

18

18043

17876

1.149

1.086

1.216

1.62E−06

5.97E−06

ACC

Low

NA

rs719725

9

A-C

14

11820

13119

0.934

0.900

0.968

2.17E−04

5.56E−04

AAC

Low

MLH1

rs63750447

3

T-A

6

1427

1491

2.449

1.426

4.205

0.001

0.002

CCC

Low

XPG

rs17655

13

G-C

8

4752

5648

1.101

1.036

1.170

0.002

0.004

AAC

Low

NAT2

rs1801280

8

T-C

3

2066

2581

0.876

0.807

0.952

0.002

0.004

AAC

Low

NA

rs11568820

12

G-A

5

4278

4693

1.112

1.036

1.194

0.003

0.006

AAC

Low

VDR

rs1544410

12

G-A

14

10404

11213

0.768

0.633

0.930

0.007

0.012

ACC

Low

CCND1

rs9344

11

G-A

21

4757

6680

1.119

1.026

1.220

0.011

0.017

ACC

Low

CDH1

rs16260

16

C-A

8

6062

7045

0.934

0.884

0.988

0.016

0.023

AAC

Low

EGF

rs4444903

4

G-A

8

1234

1377

0.819

0.692

0.969

0.020

0.027

ACC

Low

GREM1

rs16969681

15

C-T

6

7300

9039

1.157

1.022

1.311

0.021

0.028

ACA

Low

MTRR

rs1801394

5

A-G

19

8409

11893

1.046

1.004

1.089

0.030

0.036

ABC

Low

NQO1

rs1800566

16

C-T

13

6016

6905

1.142

1.013

1.288

0.030

0.036

ACC

Low

MMP9

rs3918242

20

C-T

5

829

1096

0.803

0.657

0.980

0.031

0.037

BAC

Low

ERCC1

rs11615

19

C-T

5

982

1251

1.147

1.011

1.302

0.033

0.037

AAC

Low

APC

rs459552

5

A-T

13

9440

10200

0.950

0.905

0.997

0.037

0.041

AAC

Low

CYP1A1

rs1048943

15

A-G

13

3509

3960

1.287

1.011

1.637

0.040

0.043

ACA

Low

GH1

rs2665802

17

T-A

3

2740

3198

0.929

0.863

0.999

0.046

0.047

AAC

Low

RETN

rs1862513

19

C-G

3

1013

1049

1.145

1.000

1.311

0.050

0.050

ABC

Low

  1. Chr chromosome, FDR false discovery rate
  2. aMajor alleles-minor alleles; Venice criteria: A (high), B (moderate), C (weak) credibility for three parameters (amount of evidence, heterogeneity and bias; see text and Additional file 1 for more details); level of evidence: overall level of summary evidence according to the Venice criteria